表紙
市場調查報告書
商品編碼
1071650

胰島素輸送設備市場:按類型(胰島素筆,胰島素泵,胰島素注射器),分銷渠道(藥房,糖尿病診所/中心,電子商務),最終用途(家庭/醫院)2030全球市場需求預測

Insulin Delivery Devices Market Research Report: By Type (Insulin Pen, Insulin Pump, Insulin Syringe), Distribution Channel (Pharmacies, Diabetes Clinics/Centers, E-Commerce), End Use (Home-Use, Hospitals) - Global Market Demand Forecast to 2030

出版日期: | 出版商: Prescient & Strategic Intelligence Private Limited | 英文 334 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

2021年胰島素輸送裝置的市場規模達到160.08億美元。預計到 2030 年,該市場將達到 393.718 億美元。

本報告探討了胰島素輸送設備市場,概述了市場、按類型、分銷渠道、最終用途、地區和進入市場的公司概況劃分的趨勢。

目錄

第1章調查背景

第2章調查方法

第 3 章執行摘要

第4章細分市場的定義

  • 按產品
    • 胰島素筆
      • 重複使用筆
      • 一次性筆
    • 胰島素泵
      • 外部/繫繩泵
      • 貼片泵
    • 胰島素注射器
    • 其他
  • 按分銷渠道
    • 藥房
    • 電子商務
    • 糖尿病診所/中心

第五章行業展望

  • 市場動態
    • 趨勢
      • 胰島素輸送裝置銷量快速增長
      • 家庭液體療法在糖尿病治療中的重要性日益增加
    • 促進因素
      • 越來越多的糖尿病患者
      • 胰島素輸送裝置的技術進步
      • 老齡化人口迅速增加
    • 分析增長因素對市場預測的影響
    • 抑制器
      • 嚴格的監管要求
      • 注射器的複雜製造
    • 制約因素對市場預測的影響分析
  • COVID-19 的影響
  • 波特五力分析

第6章全球市場規模與預測

  • 概覽
  • 按類型劃分的市場收入(2015-2030 年)
    • 按類型劃分的胰島素筆市場收入(2015-2030)
    • 按類型劃分的胰島素泵市場收入(2015-2030)
  • 按市場收入和分銷渠道 (2015-2030)
  • 按最終用途分列的市場利潤(2015-2030 年)
  • 各地區市場利潤 (2015-2030)

第7章北美市場規模及預測

第 8 章歐洲市場規模與預測

第9章亞太市場規模及預測

第 10 章拉丁美洲市場規模和預測

第 11 章中東/非洲市場規模和預測

第12章美國市場規模與預測

第 13 章加拿大市場規模和預測

第 14 章德國市場規模與預測

第 15 章法國市場規模和預測

第 16 章英國市場規模和預測

第 17 章意大利市場規模和預測

第 18 章西班牙市場規模和預測

第19章中國市場規模及預測

第 20 章日本市場規模和預測

第 21 章印度市場規模和預測

第 22 章巴西市場規模和預測

第 23 章墨西哥市場規模和預測

第 24 章沙特阿拉伯市場規模和預測

第 25 章南非市場規模和預測

第 26 章阿聯酋市場規模和預測

第27章競爭態勢

第28章公司簡介

  • Becton, Dickinson and Company
  • Medtronic plc
  • Tandem Diabetes Care Inc.
  • Biocon Limited
  • Eli Lilly and Company
  • Novo Nordisk A/S
  • Sanofi
  • Ypsomed AG
  • F. Hoffmann-La Roche Ltd.
  • Insulet Corporation
  • B. Braun Melsungen AG
  • Wockhardt Limited

第29章 附錄

目錄
Product Code: LS10326

The insulin delivery devices market 2030 revenue will likely be $39,371.8 million, compared to an estimated $16,008.0 million in 2021. According to the market report published by P&S Intelligence. Among all the devices used for administering this peptide hormone into the body, insulin pens are used the most. Pens are easier to use by individuals on themselves compared to syringes and cheaper compared to insulin pumps and other devices.

Moreover, reusable pens are cost-effective in the long run, as a single pen can be used for a long time just by simply changing the vial/refill. Therefore, seeing the growing popularity of these devices, companies that produce them are enhancing their sales and distribution network in countries with a large diabetic population, such as China and India. Similarly, in developed countries, technologically advanced pens and ample medical reimbursements on their purchase are available.

Key Findings of Insulin Delivery Devices Market Report

The biggest reason behind the rising demand for insulin delivery devices is diabetes, which either results in insulin resistance or the stoppage in the production of this hormone.

The IDF recorded the global prevalence of this endocrine disorder at 463 million in 2019, forecasting it to reach 578 million and 700.2 million by 2030 and 2045, respectively.

Along with this, another key driver for the insulin delivery devices market is the growing number of obese people. Obesity, which is now considered an independent risk factor for diabetes, is a result of genetics or poor lifestyle choices.

Another factor that ups the risk of this disease is aging, with a larger number of people aged above 45 years suffering from this disorder compared to younger people.

Since many of the older people are not yet as comfortable with digital technologies, pharmacies continue to be the preferred place for them to buy insulin delivery devices.

Currently, North America is the largest insulin delivery devices market because of the highly fatty diet of a large number of people, which leads to obesity and, often, diabetes. Moreover, the region has been among the first to accept technologically advanced methods of administering this hormone into the body.

In the years to come, market players will find numerous growth opportunities in the APAC region, which is home to the largest diabetic population in the world. This, combined with the increasing awareness on a strict care regimen, is propelling the sale of insulin delivery devices. Among the various kinds of insulin pens, pumps, and other devices, those meant for home use continue to be the most popular.

Thus, key insulin delivery devices market players, such as Becton, Dickinson and Company, Tandem Diabetes Care Inc., Medtronic plc, Biocon Ltd., Insulet Corporation, Eli Lilly and Company, Novo Nordisk A/S, Ypsomed Holding AG, Sanofi, F. Hoffmann-La Roche Ltd., Braun Melsungen AG, Wockhardt Ltd., and Gulf Pharmaceutical Industries, are doing more to target the at-home consumer base. A key move in this regard is the introduction of insulin delivery devices that do not require fingersticks for calibration.

Table of Contents

Chapter 1. Research Background

  • 1.1 Research Objectives
  • 1.2 Market Definition
  • 1.3 Analysis Period
  • 1.4 Market Data Reporting Unit
  • 1.5 Market Size Breakdown by Segment
    • 1.5.1 Market Segmentation by Type
    • 1.5.2 Market Segmentation by Distribution Channel
    • 1.5.3 Market Segmentation by End Use
    • 1.5.4 Market Segmentation by Region
    • 1.5.5 Market Segment Analysis of Countries
  • 1.6 Key Stakeholders

Chapter 2. Research Methodology

  • 2.1 Secondary Research
    • 2.1.1 Paid
    • 2.1.2 Unpaid
    • 2.1.3 P&S Intelligence Database
  • 2.2 Primary Research
    • 2.2.1 Breakdown of Primary Research, by Region
    • 2.2.2 Breakdown of Primary Research, by Industry Participant
    • 2.2.3 Breakdown of Primary Research, by Designation
    • 2.2.4 Breakdown of Primary Research, by Company Type
  • 2.3 Market Size Estimation
  • 2.4 Data Triangulation
  • 2.5 Currency Conversion Rates
  • 2.6 Notes and Caveats

Chapter 3. Executive Summary

Chapter 4. Definition of Market Segments

  • 4.1 By Product
    • 4.1.1 Insulin Pen
      • 4.1.1.1 Reusable pens
      • 4.1.1.2 Disposable pens
    • 4.1.2 Insulin Pump
      • 4.1.2.1 External/Tethered pumps
      • 4.1.2.2 Patch pumps
    • 4.1.3 Insulin Syringe
    • 4.1.4 Others
  • 4.2 By Distribution Channel
    • 4.2.1 Pharmacies
    • 4.2.2 E-Commerce
    • 4.2.3 Diabetes Clinics/Centers

Chapter 5. Industry Outlook

  • 5.1 Market Dynamics
    • 5.1.1 Trends
      • 5.1.1.1 Surge in the launch of insulin delivery devices
      • 5.1.1.2 Growing significance of home infusion therapy for diabetes treatment
    • 5.1.2 Drivers
      • 5.1.2.1 Growing diabetic population
      • 5.1.2.2 Technological advancements in insulin delivery devices
      • 5.1.2.3 Surging aging population
    • 5.1.3 Impact Analysis of Drivers on Market Forecast
    • 5.1.4 Restraints
      • 5.1.4.1 Stringent regulatory requirements
      • 5.1.4.2 Complex manufacturing of syringes
    • 5.1.5 Impact Analysis of Restraints on Market Forecast
  • 5.2 Impact of COVID-19
  • 5.3 Porter's Five Forces Analysis
    • 5.3.1 Bargaining Power of Buyers
    • 5.3.2 Bargaining Power of Suppliers
    • 5.3.3 Intensity of Rivalry
    • 5.3.4 Threat of New Entrants
    • 5.3.5 Threat of Substitutes

Chapter 6. Global Market Size and Forecast

  • 6.1 Overview
  • 6.2 Market Revenue, by Type (2015-2030)
    • 6.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 6.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 6.3 Market Revenue, by Distribution Channel (2015-2030)
  • 6.4 Market Revenue, by End Use (2015-2030)
  • 6.5 Market Revenue, by Region (2015-2030)

Chapter 7. North America Market Size and Forecast

  • 7.1 Overview
  • 7.2 Market Revenue, by Type (2015-2030)
    • 7.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 7.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 7.3 Market Revenue, by Distribution Channel (2015-2030)
  • 7.4 Market Revenue, by End Use (2015-2030)
  • 7.5 Market Revenue, by Country (2015-2030)

Chapter 8. Europe Market Size and Forecast

  • 8.1 Overview
  • 8.2 Market Revenue, by Type (2015-2030)
    • 8.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 8.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 8.3 Market Revenue, by Distribution Channel (2015-2030)
  • 8.4 Market Revenue, by End Use (2015-2030)
  • 8.5 Market Revenue, by Country (2015-2030)

Chapter 9. APAC Market Size and Forecast

  • 9.1 Overview
  • 9.2 Market Revenue, by Type (2015-2030)
    • 9.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 9.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 9.3 Market Revenue, by Distribution Channel (2015-2030)
  • 9.4 Market Revenue, by End Use (2015-2030)
  • 9.5 Market Revenue, by Country (2015-2030)

Chapter 10. LATAM Market Size and Forecast

  • 10.1 Overview
  • 10.2 Market Revenue, by Type (2015-2030)
    • 10.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 10.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 10.3 Market Revenue, by Distribution Channel (2015-2030)
  • 10.4 Market Revenue, by End Use (2015-2030)
  • 10.5 Market Revenue, by Country (2015-2030)

Chapter 11. MEA Market Size and Forecast

  • 11.1 Overview
  • 11.2 Market Revenue, by Type (2015-2030)
    • 11.2.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 11.2.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 11.3 Market Revenue, by Distribution Channel (2015-2030)
  • 11.4 Market Revenue, by End Use (2015-2030)
  • 11.5 Market Revenue, by Country (2015-2030)

Chapter 12. U.S. Market Size and Forecast

  • 12.1 Market Revenue, by Type (2015-2030)
    • 12.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 12.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 12.2 Market Revenue, by Distribution Channel (2015-2030)
  • 12.3 Market Revenue, by End Use (2015-2030)

Chapter 13. Canada Market Size and Forecast

  • 13.1 Market Revenue, by Type (2015-2030)
    • 13.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 13.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 13.2 Market Revenue, by Distribution Channel (2015-2030)
  • 13.3 Market Revenue, by End Use (2015-2030)

Chapter 14. Germany Market Size and Forecast

  • 14.1 Market Revenue, by Type (2015-2030)
    • 14.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 14.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 14.2 Market Revenue, by Distribution Channel (2015-2030)
  • 14.3 Market Revenue, by End Use (2015-2030)

Chapter 15. France Market Size and Forecast

  • 15.1 Market Revenue, by Type (2015-2030)
    • 15.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 15.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 15.2 Market Revenue, by Distribution Channel (2015-2030)
  • 15.3 Market Revenue, by End Use (2015-2030)

Chapter 16. U.K. Market Size and Forecast

  • 16.1 Market Revenue, by Type (2015-2030)
    • 16.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 16.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 16.2 Market Revenue, by Distribution Channel (2015-2030)
  • 16.3 Market Revenue, by End Use (2015-2030)

Chapter 17. Italy Market Size and Forecast

  • 17.1 Market Revenue, by Type (2015-2030)
    • 17.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 17.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 17.2 Market Revenue, by Distribution Channel (2015-2030)
  • 17.3 Market Revenue, by End Use (2015-2030)

Chapter 18. Spain Market Size and Forecast

  • 18.1 Market Revenue, by Type (2015-2030)
    • 18.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 18.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 18.2 Market Revenue, by Distribution Channel (2015-2030)
  • 18.3 Market Revenue, by End Use (2015-2030)

Chapter 19. China Market Size and Forecast

  • 19.1 Market Revenue, by Type (2015-2030)
    • 19.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 19.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 19.2 Market Revenue, by Distribution Channel (2015-2030)
  • 19.3 Market Revenue, by End Use (2015-2030)

Chapter 20. Japan Market Size and Forecast

  • 20.1 Market Revenue, by Type (2015-2030)
    • 20.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 20.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 20.2 Market Revenue, by Distribution Channel (2015-2030)
  • 20.3 Market Revenue, by End Use (2015-2030)

Chapter 21. India Market Size and Forecast

  • 21.1 Market Revenue, by Type (2015-2030)
    • 21.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 21.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 21.2 Market Revenue, by Distribution Channel (2015-2030)
  • 21.3 Market Revenue, by End Use (2015-2030)

Chapter 22. Brazil Market Size and Forecast

  • 22.1 Market Revenue, by Type (2015-2030)
    • 22.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 22.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 22.2 Market Revenue, by Distribution Channel (2015-2030)
  • 22.3 Market Revenue, by End Use (2015-2030)

Chapter 23. Mexico Market Size and Forecast

  • 23.1 Market Revenue, by Type (2015-2030)
    • 23.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 23.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 23.2 Market Revenue, by Distribution Channel (2015-2030)
  • 23.3 Market Revenue, by End Use (2015-2030)

Chapter 24. Saudi Arabia Market Size and Forecast

  • 24.1 Market Revenue, by Type (2015-2030)
    • 24.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 24.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 24.2 Market Revenue, by Distribution Channel (2015-2030)
  • 24.3 Market Revenue, by End Use (2015-2030)

Chapter 25. South Africa Market Size and Forecast

  • 25.1 Market Revenue, by Type (2015-2030)
    • 25.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 25.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 25.2 Market Revenue, by Distribution Channel (2015-2030)
  • 25.3 Market Revenue, by End Use (2015-2030)

Chapter 26. U.A.E. Market Size and Forecast

  • 26.1 Market Revenue, by Type (2015-2030)
    • 26.1.1 Insulin Pen Market Revenue, by Type (2015-2030)
    • 26.1.2 Insulin Pump Market Revenue, by Type (2015-2030)
  • 26.2 Market Revenue, by Distribution Channel (2015-2030)
  • 26.3 Market Revenue, by End Use (2015-2030)

Chapter 27. Competitive Landscape

  • 27.1 Market Share of Key Players (2021)
  • 27.1 List of Market Players and Their Offerings
  • 27.2 Strategic Developments Key Players
    • 27.2.1 Product Launches and Approvals
    • 27.2.2 Partnerships
    • 27.2.3 Mergers and Acquisitions
    • 27.2.4 Other Developments

Chapter 28. Company Profile

  • 28.1 Becton, Dickinson and Company
    • 28.1.1 Business Overview
    • 28.1.2 Product and Service Offerings
    • 28.1.3 Key Financial Summary
  • 28.2 Medtronic plc
    • 28.2.1 Business Overview
    • 28.2.2 Product and Service Offerings
    • 28.2.3 Key Financial Summary
  • 28.3 Tandem Diabetes Care Inc.
    • 28.3.1 Business Overview
    • 28.3.2 Product and Service Offerings
    • 28.3.3 Key Financial Summary
  • 28.4 Biocon Limited
    • 28.4.1 Business Overview
    • 28.4.2 Product and Service Offerings
    • 28.4.3 Key Financial Summary
  • 28.5 Eli Lilly and Company
    • 28.5.1 Business Overview
    • 28.5.2 Product and Service Offerings
    • 28.5.3 Key Financial Summary
  • 28.6 Novo Nordisk A/S
    • 28.6.1 Business Overview
    • 28.6.2 Product and Service Offerings
    • 28.6.3 Key Financial Summary
  • 28.7 Sanofi
    • 28.7.1 Business Overview
    • 28.7.2 Product and Service Offerings
    • 28.7.3 Key Financial Summary
  • 28.8 Ypsomed AG
    • 28.8.1 Business Overview
    • 28.8.2 Product and Service Offerings
    • 28.8.3 Key Financial Summary
  • 28.9 F. Hoffmann-La Roche Ltd.
    • 28.9.1 Business Overview
    • 28.9.2 Product and Service Offerings
    • 28.9.3 Key Financial Summary
  • 28.10 Insulet Corporation
    • 28.10.1 Business Overview
    • 28.10.2 Product and Service Offerings
    • 28.10.3 Key Financial Summary
  • 28.11 B. Braun Melsungen AG
    • 28.11.1 Business Overview
    • 28.11.2 Product and Service Offerings
    • 28.11.3 Key Financial Summary
  • 28.12 Wockhardt Limited
    • 28.12.1 Business Overview
    • 28.12.2 Product and Service Offerings
    • 28.12.3 Key Financial Summary

Chapter 29. Appendix

  • 29.1 Abbreviations
  • 29.2 Sources and References
  • 29.3 Related Reports

LIST OF FIGURES

  • FIG 1 MARKET SIZE BREAKDOWN BY SEGMENT
  • FIG 2 RESEARCH METHODOLOGY
  • FIG 3 BREAKDOWN OF PRIMARY RESEARCH, BY REGION
  • FIG 4 BREAKDOWN OF PRIMARY RESEARCH, BY INDUSTRY PARTICIPANT
  • FIG 5 BREAKDOWN OF PRIMARY RESEARCH, BY DESIGNATION
  • FIG 6 BREAKDOWN OF PRIMARY RESEARCH, BY COMPANY TYPE
  • FIG 7 DATA TRIANGULATION APPROACH
  • FIG 8 CURRENCY CONVERSION RATES FOR USD (2021)
  • FIG 9 GLOBAL INSULIN DELIVERY DEVICE MARKET SUMMARY
  • FIG 10 BARGAINING POWER OF BUYERS
  • FIG 11 BARGAINING POWER OF SUPPLIERS
  • FIG 12 INTENSITY OF RIVALRY
  • FIG 13 THREAT OF NEW ENTRANTS
  • FIG 14 THREAT OF SUBSTITUTES
  • FIG 15 GLOBAL INSULIN DELIVERY DEVICE MARKET SNAPSHOT
  • FIG 16 GLOBAL INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 17 GLOBAL INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 18 GLOBAL INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 19 GLOBAL INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 20 GLOBAL INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 21 MAJOR WORLDWIDE MARKETS FOR INSULIN DELIVERY DEVICE, $M
  • FIG 22 NORTH AMERICA INSULIN DELIVERY DEVICE MARKET SNAPSHOT
  • FIG 23 NORTH AMERICA INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 24 NORTH AMERICA INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 25 NORTH AMERICA INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 26 NORTH AMERICA INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 27 NORTH AMERICA INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 28 NORTH AMERICA INSULIN DELIVERY DEVICE MARKET REVENUE, BY COUNTRY, $M (2015-2030)
  • FIG 29 EUROPE INSULIN DELIVERY DEVICE MARKET SNAPSHOT
  • FIG 30 EUROPE INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 31 EUROPE INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 32 EUROPE INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 33 EUROPE INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 34 EUROPE INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 35 EUROPE INSULIN DELIVERY DEVICE MARKET REVENUE, BY COUNTRY, $M (2015-2030)
  • FIG 36 APAC INSULIN DELIVERY DEVICE MARKET SNAPSHOT
  • FIG 37 APAC INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 38 APAC INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 39 APAC INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 40 APAC INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 41 APAC INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 42 LATAM INSULIN DELIVERY DEVICE MARKET SNAPSHOT
  • FIG 43 LATAM INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 44 LATAM INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 45 LATAM INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 46 LATAM INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 47 LATAM INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 48 MEA INSULIN DELIVERY DEVICE MARKET SNAPSHOT
  • FIG 49 MEA INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 50 MEA INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 51 MEA INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 52 MEA INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 53 MEA INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 54 U.S. INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 55 U.S. INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 56 U.S. INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 57 U.S. INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 58 U.S. INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 59 CANADA INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 60 CANADA INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 61 CANADA INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 62 CANADA INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 63 CANADA INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 64 GERMANY INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 65 GERMANY INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 66 GERMANY INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 67 GERMANY INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 68 GERMANY INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 69 FRANCE INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 70 FRANCE INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 71 FRANCE INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 72 FRANCE INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 73 FRANCE INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 74 U.K. INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 75 U.K. INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 76 U.K. INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 77 U.K. INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 78 U.K. INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 79 ITALY INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 80 ITALY INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 81 ITALY INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 82 ITALY INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 83 ITALY INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 84 SPAIN INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 85 SPAIN INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 86 SPAIN INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 87 SPAIN INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 88 SPAIN INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 89 CHINA INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 90 CHINA INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 91 CHINA INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 92 CHINA INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 93 CHINA INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 94 JAPAN INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 95 JAPAN INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 96 JAPAN INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 97 JAPAN INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 98 JAPAN INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 99 INDIA INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 100 INDIA INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 101 INDIA INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 102 INDIA INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 103 INDIA INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 104 BRAZIL INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 105 BRAZIL INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 106 BRAZIL INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 107 BRAZIL INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 108 BRAZIL INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 109 MEXICO INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 110 MEXICO INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 111 MEXICO INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 112 MEXICO INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 113 MEXICO INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 114 SAUDI ARABIA INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 115 SAUDI ARABIA INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 116 SAUDI ARABIA INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 117 SAUDI ARABIA INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 118 SAUDI ARABIA INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 119 SOUTH AFRICA INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 120 SOUTH AFRICA INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 121 SOUTH AFRICA INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 122 SOUTH AFRICA INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 123 SOUTH AFRICA INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 124 U.A.E. INSULIN DELIVERY DEVICE MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 125 U.A.E. INSULIN PEN MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 126 U.A.E. INSULIN PUMP MARKET REVENUE, BY TYPE, $M (2015-2030)
  • FIG 127 U.A.E. INSULIN DELIVERY DEVICE MARKET REVENUE, BY DISTRIBUTION CHANNEL, $M (2015-2030)
  • FIG 128 U.A.E. INSULIN DELIVERY DEVICE MARKET REVENUE, BY END USE, $M (2015-2030)
  • FIG 129 GLOBAL INSULIN DELIVERY DEVICES MARKET SHARE ANALYSIS OF KEY PLAYERS (2020)
  • FIG 130 BECTON, DICKINSON AND COMPANY - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
  • FIG 131 MEDTRONIC PLC - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
  • FIG 132 TANDEM DIABETES CARE INC. - REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2021)
  • FIG 133 BIOCON LIMITED - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
  • FIG 134 ELI LILLY AND COMPANY - REVENUE SPLIT BY PRODUCT AND GEOGRAPHY (2021)
  • FIG 135 NOVO NORDISK A/S - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
  • FIG 136 SANOFI - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
  • FIG 137 YPSOMED AG - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
  • FIG 138 F. HOFFMANN-LA ROCHE LTD. - REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2021)
  • FIG 139 B. BRAUN MELSUNGEN AG - REVENUE SPLIT BY DIVISION AND GEOGRAPHY (2020)
  • FIG 140 WOCKHARDT LIMITED - REVENUE SPLIT BY GEOGRAPHY (2021)